JP2021098732A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021098732A5 JP2021098732A5 JP2021037440A JP2021037440A JP2021098732A5 JP 2021098732 A5 JP2021098732 A5 JP 2021098732A5 JP 2021037440 A JP2021037440 A JP 2021037440A JP 2021037440 A JP2021037440 A JP 2021037440A JP 2021098732 A5 JP2021098732 A5 JP 2021098732A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762546300P | 2017-08-16 | 2017-08-16 | |
| US201762546297P | 2017-08-16 | 2017-08-16 | |
| US62/546,300 | 2017-08-16 | ||
| US62/546,297 | 2017-08-16 | ||
| US201762552152P | 2017-08-30 | 2017-08-30 | |
| US62/552,152 | 2017-08-30 | ||
| US201762555114P | 2017-09-07 | 2017-09-07 | |
| US62/555,114 | 2017-09-07 | ||
| JP2020508477A JP2020531438A (ja) | 2017-08-16 | 2018-08-16 | Nkg2d、cd16、およびegfr、hla−e、ccr4、またはpd−l1に結合するタンパク質 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508477A Division JP2020531438A (ja) | 2017-08-16 | 2018-08-16 | Nkg2d、cd16、およびegfr、hla−e、ccr4、またはpd−l1に結合するタンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021098732A JP2021098732A (ja) | 2021-07-01 |
| JP2021098732A5 true JP2021098732A5 (cg-RX-API-DMAC7.html) | 2021-09-24 |
Family
ID=65362495
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508477A Pending JP2020531438A (ja) | 2017-08-16 | 2018-08-16 | Nkg2d、cd16、およびegfr、hla−e、ccr4、またはpd−l1に結合するタンパク質 |
| JP2021037440A Pending JP2021098732A (ja) | 2017-08-16 | 2021-03-09 | Nkg2d、cd16、およびegfr、ccr4、またはpd−l1に結合するタンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508477A Pending JP2020531438A (ja) | 2017-08-16 | 2018-08-16 | Nkg2d、cd16、およびegfr、hla−e、ccr4、またはpd−l1に結合するタンパク質 |
Country Status (12)
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110944651A (zh) | 2017-02-08 | 2020-03-31 | 蜻蜓疗法股份有限公司 | 用于自然杀伤细胞激活的多特异性结合蛋白及其治疗癌症的治疗性用途 |
| EP4273258A3 (en) | 2017-02-20 | 2024-01-17 | Dragonfly Therapeutics, Inc. | Proteins binding her2, nkg2d and cd16 |
| MX2020008333A (es) | 2018-02-08 | 2020-09-21 | Dragonfly Therapeutics Inc | Terapia de combinacion del cancer que incluye proteinas de union multiespecificas que activan a las celulas asesinas naturales. |
| CA3090244A1 (en) | 2018-02-08 | 2019-08-15 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting the nkg2d receptor |
| CN112119093A (zh) | 2018-02-20 | 2020-12-22 | 蜻蜓治疗公司 | 结合cd33、nkg2d和cd16的多特异性结合蛋白和使用方法 |
| SG11202011139YA (en) * | 2018-05-16 | 2020-12-30 | Dragonfly Therapeutics Inc | Protein binding nkg2d, cd16 and a fibroblast activation protein |
| EA202091977A1 (ru) * | 2018-05-28 | 2021-02-09 | Драгонфлай Терапьютикс, Инк. | Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения |
| CA3108427A1 (en) | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| CN113164570B (zh) | 2018-08-08 | 2024-05-14 | 蜻蜓疗法股份有限公司 | 结合nkg2d、cd16和肿瘤相关抗原的蛋白质 |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| US20230067182A1 (en) * | 2019-11-29 | 2023-03-02 | Boe Technology Group Co., Ltd. | Data Processing Device and Method, and Computer Readable Storage Medium |
| CN115708411A (zh) * | 2020-04-16 | 2023-02-21 | 南通壹宸生物医药科技有限公司 | 一种pd-1突变体多肽及其制备和用途 |
| AU2021268340A1 (en) | 2020-05-06 | 2022-12-08 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and CLEC12A |
| BR112023002116A2 (pt) * | 2020-08-05 | 2023-04-25 | Dragonfly Therapeutics Inc | Proteínas que se ligam a nkg2d, cd16 e egfr |
| CN116063550A (zh) * | 2020-09-02 | 2023-05-05 | 南京北恒生物科技有限公司 | 靶向nk激活性受体的嵌合抗原受体 |
| EP4301774A4 (en) | 2021-03-03 | 2025-08-13 | Dragonfly Therapeutics Inc | METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN |
| CN115246886A (zh) * | 2021-04-27 | 2022-10-28 | 丹生医药技术(上海)有限公司 | 一种抗egfr/vegf双功能融合蛋白及其用途 |
| EP4372001A4 (en) * | 2021-07-14 | 2025-02-12 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO HGFR AND EGFR, AND PHARMACEUTICAL USE THEREOF |
| CN116284430A (zh) * | 2021-07-30 | 2023-06-23 | 广东菲鹏制药股份有限公司 | 靶向肿瘤的il15融合蛋白及其应用 |
| WO2023043861A2 (en) * | 2021-09-16 | 2023-03-23 | Biohaven Therapeutics Ltd. | Conjugated antibodies for treating diseases |
| CN118201961A (zh) * | 2021-09-16 | 2024-06-14 | Gt生物制药公司 | Pd-l1靶向融合蛋白及其使用方法 |
| JP7767613B2 (ja) | 2021-11-15 | 2025-11-11 | システィミューン,インコーポレイテッド | 二重特異性抗体-カンプトテシン薬物複合体及びその製薬的使用 |
| EP4476263A4 (en) * | 2022-02-09 | 2026-01-28 | Dragonfly Therapeutics Inc | PHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO EGFR, NKG2D AND CD16 |
| JP2025528087A (ja) * | 2022-08-05 | 2025-08-26 | チマゲン・バイオサイエンシズ,リミテッド | 二量体化可能な腫瘍抗原及び免疫刺激抗原を標的とする多重特異性抗体 |
| CN121100134A (zh) * | 2023-04-14 | 2025-12-09 | 山东先声生物制药有限公司 | 一种靶向人cd16和肿瘤抗原的多特异性抗体 |
| CN121443647A (zh) * | 2023-07-07 | 2026-01-30 | 四川科伦博泰生物医药股份有限公司 | EGFR/c-MET双特异性结合蛋白及其用途 |
| KR20260051102A (ko) * | 2023-07-07 | 2026-04-15 | 쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 | Egfr/c-met 이중특이적 결합 단백질 및 이의 용도 |
| CN121568966A (zh) * | 2023-07-19 | 2026-02-24 | 映恩生物制药(苏州)有限公司 | 一种双特异性抗体、其药物偶联物及其用途 |
| CN121868507A (zh) * | 2024-10-16 | 2026-04-17 | 上海安领科生物医药有限公司 | 抗EGFR和cMET双特异性抗体的抗体药物偶联物 |
| WO2026098440A1 (zh) * | 2024-11-05 | 2026-05-15 | 上海齐鲁制药研究中心有限公司 | 一种双特异性抗体偶联物及其制备方法和应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1945771A1 (en) * | 2005-10-28 | 2008-07-23 | Novo Nordisk A/S | Fusion proteins that bind effector lymphocytes and target cells |
| WO2009077483A1 (en) | 2007-12-14 | 2009-06-25 | Novo Nordisk A/S | Antibodies against human nkg2d and uses thereof |
| MX2009012343A (es) * | 2007-05-14 | 2010-02-10 | Biogen Idec Inc | Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello. |
| US9273136B2 (en) | 2008-08-04 | 2016-03-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Fully human anti-human NKG2D monoclonal antibodies |
| TW201109438A (en) * | 2009-07-29 | 2011-03-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| CN105859889B (zh) * | 2010-11-17 | 2020-01-07 | 中外制药株式会社 | 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子 |
| JP6400470B2 (ja) * | 2011-05-16 | 2018-10-03 | ジェネロン(シャンハイ)コーポレイション リミテッド | 多重特異性Fab融合タンパク質および使用法 |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US9562110B2 (en) * | 2012-11-21 | 2017-02-07 | Wuhan Yzy Biopharma Co., Ltd. | Bispecific antibody |
| EP3587448B1 (en) * | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimeric proteins |
| WO2015095412A1 (en) | 2013-12-19 | 2015-06-25 | Zhong Wang | Bispecific antibody with two single-domain antigen-binding fragments |
| AU2014374055B2 (en) * | 2013-12-30 | 2018-11-08 | Epimab Biotherapeutics Inc. | Fabs-in-tandem immunoglobulin and uses thereof |
| US10647768B2 (en) * | 2014-05-29 | 2020-05-12 | Macrogenics, Inc. | Multi-chain polypeptide-containing tri-specific binding molecules |
| RU2017105425A (ru) * | 2014-08-28 | 2018-09-28 | Академиш Зикенхёйс Лейден Х.О.Д.Н. Люмк | Комбинации антитела против cd94/nkg2a и/или cd94/nkg2b и вакцины |
| CN107074961A (zh) * | 2014-11-03 | 2017-08-18 | 默克专利股份公司 | 用于生成双特异性鲨鱼可变抗体结构域的方法及其用途 |
| CA2972800A1 (en) * | 2015-01-02 | 2016-07-07 | Dyax Corp. | Bispecific antibodies against plasma kallikrein and factor xii |
| WO2016122701A1 (en) * | 2015-01-26 | 2016-08-04 | Macrogenics, Inc. | Anti-dr5 antibodies and molecules comprising dr5-binding domains thereof |
| CN107530424A (zh) | 2015-02-20 | 2018-01-02 | 俄亥俄州国家创新基金会 | 针对nkg2d和肿瘤相关抗原的二价抗体 |
| US20180147257A1 (en) * | 2015-05-22 | 2018-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Btn3a ectodomain proteins and methods of use |
| GB201517538D0 (en) * | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| IL304871A (en) * | 2016-01-11 | 2023-10-01 | Inhibrx Inc | Multispecific and multivalent binding fusion proteins - 41BB, preparations containing them and their uses |
| CN109071632B (zh) * | 2016-02-05 | 2022-12-30 | 奥里尼斯生物科学私人有限公司 | 靶向性治疗剂及其用途 |
| AU2017222700B2 (en) * | 2016-02-26 | 2018-09-27 | Imunexus Therapeutics Limited | Multi-specific molecules |
-
2018
- 2018-08-16 KR KR1020217006762A patent/KR20210029298A/ko not_active Abandoned
- 2018-08-16 US US16/638,559 patent/US20200216544A1/en not_active Abandoned
- 2018-08-16 CA CA3073117A patent/CA3073117A1/en not_active Abandoned
- 2018-08-16 WO PCT/US2018/000212 patent/WO2019035939A1/en not_active Ceased
- 2018-08-16 CN CN202110256674.8A patent/CN113004391A/zh active Pending
- 2018-08-16 KR KR1020207007137A patent/KR20200037388A/ko not_active Ceased
- 2018-08-16 MX MX2020001805A patent/MX2020001805A/es unknown
- 2018-08-16 BR BR112020003050-3A patent/BR112020003050A2/pt not_active IP Right Cessation
- 2018-08-16 CN CN201880053214.1A patent/CN111065649A/zh active Pending
- 2018-08-16 SG SG10202102251YA patent/SG10202102251YA/en unknown
- 2018-08-16 EP EP21164058.6A patent/EP3882270A3/en not_active Withdrawn
- 2018-08-16 CA CA3112990A patent/CA3112990A1/en active Pending
- 2018-08-16 CA CA3176049A patent/CA3176049A1/en active Pending
- 2018-08-16 SG SG11201913969SA patent/SG11201913969SA/en unknown
- 2018-08-16 EP EP18846836.7A patent/EP3668893A4/en not_active Withdrawn
- 2018-08-16 JP JP2020508477A patent/JP2020531438A/ja active Pending
- 2018-08-16 AU AU2018318698A patent/AU2018318698A1/en not_active Abandoned
-
2020
- 2020-02-09 IL IL272553A patent/IL272553A/en unknown
- 2020-02-14 MX MX2021002969A patent/MX2021002969A/es unknown
-
2021
- 2021-03-01 US US17/188,978 patent/US20210261668A1/en not_active Abandoned
- 2021-03-05 AU AU2021201451A patent/AU2021201451A1/en not_active Abandoned
- 2021-03-07 IL IL281305A patent/IL281305A/en unknown
- 2021-03-09 JP JP2021037440A patent/JP2021098732A/ja active Pending